LATAM Technology Reporter
SEE OTHER BRANDS

Daily news on science and technology in Latin America

LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

Press releases published on May 14, 2025

Pinnacle Career Institute Expands GWO Training with Critical Bolt Tightening Module

Pinnacle Career Institute Expands GWO Training with Critical Bolt Tightening Module

PCI adds GWO Bolt Tightening training to enhance wind turbine safety, prevent costly mistakes, and build technician confidence. KANSAS CITY, MO, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- Pinnacle Career Institute (PCI) is enhancing its Global …

Jakub Leps Promoted to General Manager of Newsmatics Data Sciences

Jakub Leps Promoted to General Manager of Newsmatics Data Sciences

Leps to lead strategy and operations at the forefront of data innovation WASHINGTON, DC, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- Newsmatics, a news technology company known for its suite of innovative digital media products, is proud to …

Protegiendo la Certificación TALQ – Un Caso de Vigilancia

Protegiendo la Certificación TALQ – Un Caso de Vigilancia

El Consorcio TALQ descubre una certificación falsificada PISCATAWAY, NJ, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- El Consorcio TALQ, desarrollador del Protocolo TALQ para Ciudades Inteligentes—un estándar global de interfaz para aplicaciones de …

Amblyopia (lazy eye) treatment expands in the digital therapeutics space with the launch of a new solution

Amblyopia (lazy eye) treatment expands in the digital therapeutics space with the launch of a new solution

NEW YORK, NY, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- A groundbreaking new treatment from Scottish startup Eyesight Electronics has enabled a patient, once classified as legally blind, to recover over 50 percent of their vision in just three …

THE BANCORP 48 HOUR DEADLINE ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK

THE BANCORP 48 HOUR DEADLINE ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK

NEW ORLEANS, May 14, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against The Bancorp, Inc. …

After iOS Traction, AI Pet Travel App Kruiz, Announces Android Launch

After iOS Traction, AI Pet Travel App Kruiz, Announces Android Launch

Irvine, California, May 14, 2025 (GLOBE NEWSWIRE) -- Co-founders Brad Pauer and Angela Le had confirmed—twice—that their dog could fly in-cabin on a trip to London. But a last-minute policy change at Heathrow Airport left them stranded, out thousands of …

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results

CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 …

Quorum Announces Q1 2025 Results Release Date, Conference Call and Webcast Details

Quorum Announces Q1 2025 Results Release Date, Conference Call and Webcast Details

CALGARY, Alberta, May 14, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment …

Results of Voting for Directors at Annual and Special Shareholders' Meeting

Results of Voting for Directors at Annual and Special Shareholders' Meeting

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) announces the results of the vote on directors at the Annual and …

Lithium Argentina Reports First Quarter 2025 Results

Lithium Argentina Reports First Quarter 2025 Results

ZUG, Switzerland, May 14, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) today announced its first quarter 2025 results. Unless otherwise stated, results are presented in United States dollar. …

Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences: …

Jasper Therapeutics to Present at Upcoming Investor Conferences

Jasper Therapeutics to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT to address mast cell driven …

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experience Announced selection of IL15-superagonist as first payload to be delivered into tumors with Calidi’s first lead candidate using …

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

DEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean …

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using …

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and …

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Continued operational excellence leading to acceleration of multiple timelines: ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout expected in …

HP Inc. Declares Dividend

HP Inc. Declares Dividend

PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock. The dividend, the third in HP’s fiscal year 2025, is payable on July 2, 2025, to stockholders of record …

X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress

X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress

Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor Majority of physicians and chronic neutropenia participants chose to significantly reduce G-CSF dosing when using mavorixafor in …

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 14, 2025- GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service